2016
DOI: 10.1515/nanoph-2016-0101
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances in nanoplasmonic biosensors: applications and lab-on-a-chip integration

Abstract: Abstract:Motivated by the recent progress in the nanofabrication field and the increasing demand for cost-effective, portable, and easy-to-use point-of-care platforms, localized surface plasmon resonance (LSPR) biosensors have been subjected to a great scientific interest in the last few years. The progress observed in the research of this nanoplasmonic technology is remarkable not only from a nanostructure fabrication point of view but also in the complete development and integration of operative devices and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
146
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 231 publications
(154 citation statements)
references
References 71 publications
0
146
0
1
Order By: Relevance
“…Such optical sensor elements can be sensitive enough to be used in biosensors for monitoring/recognition of molecular scale interactions. [13,14]. The sensitivity of LSPR based devices strongly depends on the used material and also on the size and geometry of the metallic nanoparticles [15].…”
Section: Introductionmentioning
confidence: 99%
“…Such optical sensor elements can be sensitive enough to be used in biosensors for monitoring/recognition of molecular scale interactions. [13,14]. The sensitivity of LSPR based devices strongly depends on the used material and also on the size and geometry of the metallic nanoparticles [15].…”
Section: Introductionmentioning
confidence: 99%
“…The isolated CTCs and EVs are subsequently detected by fluorescent visualization or electrochemical and plasmonic sensing, etc., and their molecular biomarkers (e.g., proteins, DNA, and RNA) are analyzed by immunostaining, reverse transcription‐polymerase chain reaction (RT‐PCR), and sequencing, etc. ( Figure ) . Various nanomaterials, nanostructures, and molecular probes have been developed for the enrichment and analysis of CTCs and EVs, and have been successfully applied in the clinic, showing the potential of nanotechnology‐based liquid biopsy in early diagnosis, dynamic monitoring, treatment response evaluation, point‐of‐care testing (POCT), and prognosis prediction ( Figure ) .…”
Section: Advances and Challenges Of Nanotechnology‐based Liquid Biopsymentioning
confidence: 99%
“…The rapid advances in nanotechnologies have significantly boosted the performance of traditional optical biosensors, offering a new level of sensitivity (see section 13), enhanced specificity (see section 12), as well as improved integration capability [140]. This section will discuss the current challenges and future opportunities of nanobiosensing technologies in drug discovery.…”
Section: Nanobiosensors For Drug Discoverymentioning
confidence: 99%